scholarly article | Q13442814 |
P356 | DOI | 10.1074/JBC.270.25.15059 |
P698 | PubMed publication ID | 7797488 |
P2093 | author name string | B Z Levi | |
G Neufeld | |||
T Cohen | |||
S M Greenberg | |||
H Gitay-Goren | |||
S Gengrinovitch | |||
T E Maione | |||
P Rockwell | |||
P433 | issue | 25 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 15059-15065 | |
P577 | publication date | 1995-06-01 | |
P1433 | published in | Journal of Biological Chemistry | Q867727 |
P1476 | title | Platelet factor-4 inhibits the mitogenic activity of VEGF121 and VEGF165 using several concurrent mechanisms | |
P478 | volume | 270 |
Q74261766 | 2.5 kDa and 5.0 kDa heparin fragments specifically inhibit microvessel sprouting and network formation in VEGF165-mediated mammalian angiogenesis |
Q24303828 | An alternatively spliced variant of CXCR3 mediates the inhibition of endothelial cell growth induced by IP-10, Mig, and I-TAC, and acts as functional receptor for platelet factor 4 |
Q35048828 | Analysis of the role of chemokines in angiogenesis. |
Q35196548 | Angiogenesis and antiangiogenic strategies in pancreatic cancer |
Q36308980 | Angiogenesis inhibitor TNP-470 suppresses growth of peritoneal disseminating foci of human colon cancer line Lovo |
Q36166483 | Angiogenesis inhibitors found within the haemostasis pathway. |
Q34587184 | Angiogenic effects of extracellular human immunodeficiency virus type 1 Tat protein and its role in the pathogenesis of AIDS-associated Kaposi's sarcoma |
Q34786603 | Angiostatic, tumor inflammatory and anti-tumor effects of CXCL4(47-70) and CXCL4L1(47-70) in an EGF-dependent breast cancer model |
Q93353440 | Antiangiogenic Gene Therapy in Cancer |
Q30864689 | Arginine-rich anti-vascular endothelial growth factor peptides inhibit tumor growth and metastasis by blocking angiogenesis |
Q33698057 | CXCL10 Can Inhibit Endothelial Cell Proliferation Independently of CXCR3 |
Q42256799 | Capacity of wild-type and chemokine-armed parvovirus H-1PV for inhibiting neo-angiogenesis |
Q26778691 | Chemokine Regulation of Angiogenesis During Wound Healing |
Q30438032 | Chemokines as mediators of neovascularization |
Q74446280 | Corticosteroids inhibit the expression of the vascular endothelial growth factor gene in human vascular smooth muscle cells |
Q33426878 | Effect of heparin on the biological properties and molecular signature of human mesenchymal stem cells |
Q73031500 | Endothelial cell mitogenesis induced by LPA: inhibition by thrombospondin-1 and thrombospondin-2 |
Q92403252 | Exploring the Extracellular Regulation of the Tumor Angiogenic Interaction Network Using a Systems Biology Model |
Q36489766 | Extracellular angiogenic growth factor interactions: an angiogenesis interactome survey |
Q40632344 | Fibroblast growth factor receptor‐1 mediates the inhibition of endothelial cell proliferation and the promotion of skeletal myoblast differentiation by SPARC: A role for protein kinase A |
Q35540003 | Generation and Characterization of a New Monoclonal Antibody Against CXCL4. |
Q40915145 | Growth factors in angiogenesis: current interest and therapeutic potential |
Q38418286 | Heparin/Heparan sulfate proteoglycans glycomic interactome in angiogenesis: biological implications and therapeutical use. |
Q52717949 | Human Cancer and Platelet Interaction, a Potential Therapeutic Target. |
Q91645673 | Human Umbilical Tissue-Derived Cells Secrete Soluble VEGFR1 and Inhibit Choroidal Neovascularization |
Q35743028 | Inhibitory effect of Samul-tang on retinal neovascularization in oxygen-induced retinopathy |
Q37364433 | MKEY, a Peptide Inhibitor of CXCL4-CCL5 Heterodimer Formation, Protects Against Stroke in Mice |
Q42532137 | Megakaryocytes regulate the quiescence of hematopoietic stem cells through PF4: 2013 ASH meeting highlights |
Q40915825 | Mutations uncouple human fibroblast growth factor (FGF)-7 biological activity and receptor binding and support broad specificity in the secondary receptor binding site of FGFs. |
Q37518830 | Osteoblasts secrete Cxcl9 to regulate angiogenesis in bone |
Q74307955 | PF4 inhibits thrombin-stimulated MMP-1 and MMP-3 metalloproteinase expression in human vascular endothelial cells |
Q36688537 | Plasma IP-10, apoptotic and angiogenic factors associated with fatal cerebral malaria in India |
Q51032187 | Platelet Factor 4 Binds to Vascular Proteoglycans and Controls Both Growth Factor Activities and Platelet Activation. |
Q90261049 | Platelet activation in experimental murine neonatal pulmonary hypertension |
Q37705023 | Platelet-derived chemokines: pathophysiology and therapeutic aspects |
Q37734218 | Protective or pathogenic effects of vascular endothelial growth factor (VEGF) as potential biomarker in cerebral malaria |
Q36960001 | Role of platelet chemokines, PF-4 and CTAP-III, in cancer biology. |
Q35300661 | Role of vascular permeability factor/vascular endothelial growth factor in eye disease |
Q84779952 | Serum protein signature may improve detection of ductal carcinoma in situ of the breast |
Q41140250 | Similarities and differences between the vascular endothelial growth factor (VEGF) splice variants |
Q33912018 | Target molecules for anti-angiogenic therapy: from basic research to clinical trials |
Q30441368 | The CXC-chemokine CXCL4 interacts with integrins implicated in angiogenesis |
Q28547610 | The Fibrin Matrix Regulates Angiogenic Responses within the Hemostatic Microenvironment through Biochemical Control |
Q57812382 | The Role of Chemokines in Wound Healing |
Q40127968 | The VEGF angiogenic switch of fibroblasts is regulated by MMP-7 from cancer cells |
Q24291904 | The chemokine CXCL13 (BCA-1) inhibits FGF-2 effects on endothelial cells |
Q34425462 | The hemostatic system and angiogenesis in malignancy. |
Q37863514 | The role of chemokines and their receptors in angiogenesis |
Q64096591 | Variability of serum novel serum peptide biomarkers correlates with the disease states of multiple myeloma |
Q36292182 | Vascular endothelial growth factor (VEGF) mRNA isoform expression pattern is correlated with liver metastasis and poor prognosis in colon cancer |
Search more.